149 related articles for article (PubMed ID: 16354004)
1. Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development.
Wilson WI; Peng Y; Augsburger LL
AAPS PharmSciTech; 2005 Oct; 6(3):E449-57. PubMed ID: 16354004
[TBL] [Abstract][Full Text] [Related]
2. Comparison of statistical analysis and Bayesian Networks in the evaluation of dissolution performance of BCS Class II model drugs.
Wilson WI; Peng Y; Augsburger LL
J Pharm Sci; 2005 Dec; 94(12):2764-76. PubMed ID: 16258987
[TBL] [Abstract][Full Text] [Related]
3. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
M K; Sistla R; Shastri NR
Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
[TBL] [Abstract][Full Text] [Related]
4. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
5. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
Adesunloye TA; Stach PE
Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
[TBL] [Abstract][Full Text] [Related]
7. Application of QbD principles for the evaluation of empty hard capsules as an input parameter in formulation development and manufacturing.
Stegemann S; Connolly P; Matthews W; Barnett R; Aylott M; Schrooten K; Cadé D; Taylor A; Bresciani M
AAPS PharmSciTech; 2014 Jun; 15(3):542-9. PubMed ID: 24526655
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
[TBL] [Abstract][Full Text] [Related]
10. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
[TBL] [Abstract][Full Text] [Related]
11. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
12. Potential application of silicified microcrystalline cellulose in direct-fill formulations for automatic capsule-filling machines.
Guo M; Augsburger LL
Pharm Dev Technol; 2003; 8(1):47-59. PubMed ID: 12665197
[TBL] [Abstract][Full Text] [Related]
13. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
[TBL] [Abstract][Full Text] [Related]
14. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
Garbacz G; Cadé D; Benameur H; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
[TBL] [Abstract][Full Text] [Related]
15. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
16. Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: a case study using the BCS/BDDCS Class II drug nifedipine.
Patel N; Polak S; Jamei M; Rostami-Hodjegan A; Turner DB
Eur J Pharm Sci; 2014 Jun; 57():240-9. PubMed ID: 24060671
[TBL] [Abstract][Full Text] [Related]
17. Liquid Filled Hard Shell Capsules: Current Drug Delivery Influencing Pharmaceutical Technology.
Nirale P; Arora S; Solanki A; Bhat J; Singh RK; Yadav KS
Curr Drug Deliv; 2022; 19(2):238-249. PubMed ID: 33645480
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers.
Chong RH; Jones BE; Díez F; Birchall JC; Coulman SA
Int J Pharm; 2016 Mar; 500(1-2):316-25. PubMed ID: 26806464
[TBL] [Abstract][Full Text] [Related]
19. Imprinting on empty hard gelatin capsule shells containing titanium dioxide by application of the UV laser printing technique.
Hosokawa A; Kato Y; Terada K
Drug Dev Ind Pharm; 2014 Aug; 40(8):1047-53. PubMed ID: 23786207
[TBL] [Abstract][Full Text] [Related]
20. Impact of the digital revolution on the future of pharmaceutical formulation science.
Leuenberger H; Leuenberger MN
Eur J Pharm Sci; 2016 May; 87():100-11. PubMed ID: 26876764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
